Related Experiment Video
Updated: Feb 13, 2026
06:06
Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
Published on: May 9, 2022
3.2K
Nano-Driven Dual Ferroptosis Inhibition for Diabetic Periodontitis Therapy
1State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Department of Prosthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.
Journal of Dental Research
|February 11, 2026
Summary
Diabetic periodontitis is linked to ferroptosis, a cell death pathway. New FGZ nanoparticles effectively inhibit ferroptosis by targeting dual pathways, promoting periodontal tissue regeneration.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Periodontology
Background:
- Diabetic periodontitis is a major public health concern, increasing systemic disease risk and posing therapeutic challenges.
- Conventional treatments for diabetic periodontitis are often ineffective at addressing underlying molecular mechanisms.
- Ferroptosis, an iron-dependent cell death, is increasingly recognized as a key factor in diabetic periodontitis pathology.
Purpose of the Study:
- To develop a novel nanoplatform for effective ferroptosis inhibition in diabetic periodontitis.
- To investigate the synergistic effects of gallium ions and ferrostatin-1 delivered via a bimetallic ZIF-8 nanoplatform (FGZ NPs).
- To evaluate the therapeutic potential of FGZ NPs in promoting periodontal tissue regeneration.
Main Methods:
- Engineered bimetallic ZIF-8 codelivery nanoplatform (FGZ NPs) for sustained release of gallium ions (Ga³⁺) and ferrostatin-1 (Fer-1).
- Assessed the activation of the Nrf2/HO-1 cytoprotective pathway by FGZ NPs.
- Evaluated the capacity of FGZ NPs to reestablish iron homeostasis and enhance antioxidant capacity for dual-pathway ferroptosis inhibition.
- Quantified the therapeutic outcomes, including periodontal tissue regeneration, in a model of diabetic periodontitis.
Main Results:
- FGZ NPs effectively inhibited ferroptosis through dual-pathway targeting, activating the Nrf2/HO-1 pathway.
- The nanoplatform successfully reestablished iron homeostasis and bolstered antioxidant defenses.
- FGZ NPs demonstrated significant promotion of damaged periodontal tissue regeneration.
- The study highlights the limitations of single-pathway ferroptosis inhibitors.
Conclusions:
- Ferroptosis is a validated therapeutic target for diabetic periodontitis.
- The developed FGZ NPs offer a novel and effective strategy for dual-pathway ferroptosis inhibition.
- This research provides a new design paradigm for biomaterials targeting ferroptosis-related diseases.
Related Concept Videos
00:46Feedback Inhibition
57.3K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.3K
01:20Pathophysiology of Diabetes
3.7K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.7K
01:30Enzyme Inhibition
92.8K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.8K
00:59Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
01:27ATP Driven Pumps I: An Overview
9.9K
ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
9.9K
02:34Inhibition of Cdk Activity
6.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K